Bhandari, S., Rankawat, G., & Singh, A. (2021). Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients. Indian J Crit Care Med.
Citação norma ChicagoBhandari, Sudhir, Govind Rankawat, and Ajeet Singh. "Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients." Indian J Crit Care Med 2021.
Citação norma MLABhandari, Sudhir, Govind Rankawat, and Ajeet Singh. "Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients." Indian J Crit Care Med 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.